Find clinical trials for Lung Cancer in Baltimore, MD
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Lung Cancer trials near Baltimore, MD, USA:
Pembrolizumab in first line patients with squamous non-small cell lung cancer and non-squamous non-small cell lung cancer...
Phase 2
Fairfax, Virginia, United States and 2 other locations
chemotherapy (carboplatin and pemetrexed) in people with metastatic lung cancer that has a change (mutation) in the gene EGFR. Osim ...
Phase 2
Baltimore, Maryland, United States and 17 other locations
a prospective, open-label, multi-cohort, non-randomized, multicenter phase 2 study evaluating LN-145 in patients with metastatic non-small-cell lung...
Phase 2
Baltimore, Maryland, United States and 83 other locations
This is a study of the efficacy, pharmacokinetics, and safety of DS-1062a in participants with advanced or metastatic non-small cell lung ca...
Phase 2
Chevy Chase, Maryland, United States and 84 other locations
This phase II clinical trial will study the safety and efficacy of onvansertib to treat patients with small cell lung cancer (SCLC)...
Phase 2
Baltimore, Maryland, United States and 1 other location
open label, Phase 1b study of NXP900 in combination with osimertinib in subjects with advanced, progressing, EGFR-mutated non-small cell lung...
Phase 1
Fairfax, Virginia, United States and 2 other locations
BMS-986489 (Atigotatug + Nivolumab) vs Durvalumab in Limited-stage Small-cell Lung Cancer (TIGOS-LS)
combination) vs durvalumab in limited-stage (LS)-small-cell lung cancer (SCLC) participants.The main goals of this study are to:* E...
Phase 2
Fairfax, Virginia, United States and 26 other locations
with advanced/metastatic or relapsed/progressive small cell lung cancer (SCLC) and non small cell lung cancer (NS...
Phase 1, Phase 2
Fairfax, Virginia, United States and 37 other locations
the safety and tolerability of itacitinib in combination with osimertinib in subjects with locally advanced or metastatic non-small cell lung...
Phase 1, Phase 2
Washington D.C., District of Columbia, United States and 30 other locations
Researchers are investigating new treatments for untreated advanced non-small cell lung cancer (NSCLC), which is the most common fo ...
Phase 2
Baltimore, Maryland, United States and 37 other locations
Clinical trials
Research sites
Resources
Legal